Cargando…

The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model

BACKGROUND: Salmonella enterica serovar Enteritidis, the most common cause of human gastroenteritis, employs several virulence factors including lipopolysaccharide (LPS) for infection and establishment of disease inside the host. The LPS of S. enterica serovar Enteritidis consists of lipid A, core o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaiswal, Sangeeta, Pati, Niladri Bhusan, Dubey, Manupriyam, Padhi, Chandrashekhar, Sahoo, Prakash Kumar, Ray, Shilpa, Arunima, Aryashree, Mohakud, Nirmal Kumar, Suar, Mrutyunjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559907/
https://www.ncbi.nlm.nih.gov/pubmed/26346801
http://dx.doi.org/10.1186/s13099-015-0070-4
_version_ 1782388854514253824
author Jaiswal, Sangeeta
Pati, Niladri Bhusan
Dubey, Manupriyam
Padhi, Chandrashekhar
Sahoo, Prakash Kumar
Ray, Shilpa
Arunima, Aryashree
Mohakud, Nirmal Kumar
Suar, Mrutyunjay
author_facet Jaiswal, Sangeeta
Pati, Niladri Bhusan
Dubey, Manupriyam
Padhi, Chandrashekhar
Sahoo, Prakash Kumar
Ray, Shilpa
Arunima, Aryashree
Mohakud, Nirmal Kumar
Suar, Mrutyunjay
author_sort Jaiswal, Sangeeta
collection PubMed
description BACKGROUND: Salmonella enterica serovar Enteritidis, the most common cause of human gastroenteritis, employs several virulence factors including lipopolysaccharide (LPS) for infection and establishment of disease inside the host. The LPS of S. enterica serovar Enteritidis consists of lipid A, core oligosaccharide and O-antigen (OAg). The OAg consists of repeating units containing different sugars. The sugars of OAg are synthesized and assembled by a set of enzymes encoded by genes organized into clusters. Present study focuses on the effect of deletion of genes involved in biosynthesis of OAg repeating units on resistance to antimicrobial peptides and virulence in mice. METHODS: In the present study, the OAg biosynthesis was impaired by deleting tyv, prt and wbaV genes involved in tyvelose biosynthesis and its transfer to OAg. The virulence phenotype of resulting mutants was evaluated by assessing resistance to antimicrobial peptides, serum complement, adhesion, invasion and in vivo colonization. RESULTS: Deletion of the above three genes resulted in the production of OAg-negative LPS. All the OAg-negative mutants showed phenotype reported for rough strains. Interestingly, ΔwbaV mutant showed increased resistance against antimicrobial peptides and normal human serum. In addition, the ΔwbaV mutant also showed increased adhesion and invasion as compared to the other two O-Ag negative mutants Δtyv and Δprt. In vivo experiments also confirmed the increased virulent phenotype of ΔwbaV mutant as compared to Δprt mutant. CONCLUSION: OAg-negative mutants are known to be avirulent; however, this study demonstrates that certain OAg negative mutants e.g. ∆wbaV may also show resistance to antimicrobial peptides and cause colitis in Streptomyces pretreated mouse model.
format Online
Article
Text
id pubmed-4559907
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45599072015-09-05 The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model Jaiswal, Sangeeta Pati, Niladri Bhusan Dubey, Manupriyam Padhi, Chandrashekhar Sahoo, Prakash Kumar Ray, Shilpa Arunima, Aryashree Mohakud, Nirmal Kumar Suar, Mrutyunjay Gut Pathog Research BACKGROUND: Salmonella enterica serovar Enteritidis, the most common cause of human gastroenteritis, employs several virulence factors including lipopolysaccharide (LPS) for infection and establishment of disease inside the host. The LPS of S. enterica serovar Enteritidis consists of lipid A, core oligosaccharide and O-antigen (OAg). The OAg consists of repeating units containing different sugars. The sugars of OAg are synthesized and assembled by a set of enzymes encoded by genes organized into clusters. Present study focuses on the effect of deletion of genes involved in biosynthesis of OAg repeating units on resistance to antimicrobial peptides and virulence in mice. METHODS: In the present study, the OAg biosynthesis was impaired by deleting tyv, prt and wbaV genes involved in tyvelose biosynthesis and its transfer to OAg. The virulence phenotype of resulting mutants was evaluated by assessing resistance to antimicrobial peptides, serum complement, adhesion, invasion and in vivo colonization. RESULTS: Deletion of the above three genes resulted in the production of OAg-negative LPS. All the OAg-negative mutants showed phenotype reported for rough strains. Interestingly, ΔwbaV mutant showed increased resistance against antimicrobial peptides and normal human serum. In addition, the ΔwbaV mutant also showed increased adhesion and invasion as compared to the other two O-Ag negative mutants Δtyv and Δprt. In vivo experiments also confirmed the increased virulent phenotype of ΔwbaV mutant as compared to Δprt mutant. CONCLUSION: OAg-negative mutants are known to be avirulent; however, this study demonstrates that certain OAg negative mutants e.g. ∆wbaV may also show resistance to antimicrobial peptides and cause colitis in Streptomyces pretreated mouse model. BioMed Central 2015-09-03 /pmc/articles/PMC4559907/ /pubmed/26346801 http://dx.doi.org/10.1186/s13099-015-0070-4 Text en © Jaiswal et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jaiswal, Sangeeta
Pati, Niladri Bhusan
Dubey, Manupriyam
Padhi, Chandrashekhar
Sahoo, Prakash Kumar
Ray, Shilpa
Arunima, Aryashree
Mohakud, Nirmal Kumar
Suar, Mrutyunjay
The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model
title The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model
title_full The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model
title_fullStr The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model
title_full_unstemmed The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model
title_short The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model
title_sort o-antigen negative ∆wbav mutant of salmonella enterica serovar enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559907/
https://www.ncbi.nlm.nih.gov/pubmed/26346801
http://dx.doi.org/10.1186/s13099-015-0070-4
work_keys_str_mv AT jaiswalsangeeta theoantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT patiniladribhusan theoantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT dubeymanupriyam theoantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT padhichandrashekhar theoantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT sahooprakashkumar theoantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT rayshilpa theoantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT arunimaaryashree theoantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT mohakudnirmalkumar theoantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT suarmrutyunjay theoantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT jaiswalsangeeta oantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT patiniladribhusan oantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT dubeymanupriyam oantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT padhichandrashekhar oantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT sahooprakashkumar oantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT rayshilpa oantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT arunimaaryashree oantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT mohakudnirmalkumar oantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel
AT suarmrutyunjay oantigennegativewbavmutantofsalmonellaentericaserovarenteritidisshowsadaptiveresistancetoantimicrobialpeptidesandelicitscolitisinstreptomycinpretreatedmousemodel